Can we identify types of back pain patients that respond better to treatments?
Eight pages on PainSci cite Saragiotto 2017: 1. The Complete Guide to Low Back Pain 2. The Complete Guide to Chronic Tension Headaches 3. The Complete Guide to Neck Pain & Cricks 4. The Chiropractic Controversies 5. Does Spinal Manipulation Work? 6. Cognitive Behavioural Therapy for Chronic Pain 7. Massage for back pain: an interesting scientific flip-flop 8. The outliers: do scientific trials obscure some good treatment results?
PainSci commentary on Saragiotto 2017: ?This page is one of thousands in the PainScience.com bibliography. It is not a general article: it is focused on a single scientific paper, and it may provide only just enough context for the summary to make sense. Links to other papers and more general information are provided wherever possible.
These authors conclude that the idea that some back pain patients respond better to some treatments is probably still mostly hype.
Most low back pain has no known cause and is therefore considered “non-specific,” and there’s a wide range of response to treatment in these patients. A common assumption is that they actually have specific causes for their pain, even though we can’t identify them — but there is a hope that we can identify the patients who respond to specific treatments. This is the hope or hype about “subgrouping”: you don’t necessary have to understand how their pain works to identify types of patients that will respond better to treatment. There is a large, enthusiastic movement in back pain research to achieve this.
In this paper, in which the authors thoroughly “have deliberately chosen to argue 2 extreme positions,” both for and against the investigation of subgroups. Key points in favour:
- One size fits all does not work well; non-specific back pain is clearly not all the same beast.
- Research methods are improving, and there are some good examples of subgroup analysis
- Subgrouping does not need to be complex or difficult, and there are success stories in other areas of medicine (e.g. subgroups of stroke victims).
- Subgrouping patients with nonspecific LBP fits well into the “personalized medicine” movement.
- Both patients and clinicians prefer the subgroup approach.
And key points against:
- Subgroup analyses are mostly very low quality still, and “authors commonly overstate their claims of subgroup effect.”
- Identifying stronger treatment effects for certain patients without a clear biological reason for why it works is not very persuasive, and by definition “there is no identified biological source of nonspecic LBP.”
- If some subgroups respond well to treatment, there should also be groups that respond poorly, and this evidence is missing.
- Clinicians cannot actually perceive the treatment effects that their enthusiasm for subgrouping is largely based on.
- “Subgroup analyses are associated with a high risk of false-positive and false-negative results” and may mislead us.
They conclude: “the current research initiatives and achievements in this field are far from optimal and not yet ready to be implemented in clinical practice.”
original abstract †Abstracts here may not perfectly match originals, for a variety of technical and practical reasons. Some abstacts are truncated for my purposes here, if they are particularly long-winded and unhelpful. I occasionally add clarifying notes. And I make some minor corrections.
Clinicians and clinical researchers share a common goal of achieving better outcomes for patients with low back pain (LBP). For that, randomized controlled trials and systematic reviews are the most reliable study designs to determine the effects of interventions. Subgroup analyses in these research designs have been used to examine treatment-effect modification across subgroups defined by patient characteristics. In this Viewpoint, the authors present supporting and opposing arguments for the subgrouping approach in nonspecific LBP, considering the progress made so far in the LBP field and the relevant literature in adjacent fields. J Orthop Sports Phys Ther 2017;47(2):44-48. doi:10.2519/jospt.2017.0602.
related content
- “Analgesic effects of treatments for non-specific low back pain: a meta-analysis of placebo-controlled randomized trials,” Machado et al, Rheumatology (Oxford), 2009.
- “Analgesic effects of non-surgical and non-interventional treatments for low back pain: a systematic review and meta-analysis of placebo-controlled randomised trials,” Cashin et al, BMJ Evid Based Med, 2025.
- “A systematic review reveals that the credibility of subgroup claims in low back pain trials was low,” Saragiotto et al, J Clin Epidemiol, 2016.
- “Chronic low back pain is highly individualised: patterns of classification across three unidimensional subgrouping analyses,” Rabey et al, Scand J Pain, 2019.
This page is part of the PainScience BIBLIOGRAPHY, which contains plain language summaries of thousands of scientific papers & others sources. It’s like a highly specialized blog. A few highlights:
- Long-Term Effects of Repeated Injections of Local Anesthetic With or Without Corticosteroid for Lumbar Spinal Stenosis: A Randomized Trial. Friedly 2017 Arch Phys Med Rehabil.
- Cannabis-based medicines for chronic neuropathic pain in adults. Ateş 2026 Cochrane Database Syst Rev.
- Effect of exercise on depression and anxiety symptoms: systematic umbrella review with meta-meta-analysis. Munro 2026 Br J Sports Med.
- Optimizing elastic band resistance training for Metabolic Syndrome components in older adults: A systematic review, meta-analysis, and meta-regression of randomized controlled trials. Saez-Berlanga 2026 Arch Phys Med Rehabil.
- Prevalence of Tendon Rupture and Tendinopathies Among Patients with Atherosclerotic Cardiovascular Disease Derived From United States Administrative Claims Data. Gillard 2024 Cardiol Ther.